EP1874340A4 - Elastin protective polyphenolics and methods of using the same - Google Patents

Elastin protective polyphenolics and methods of using the same

Info

Publication number
EP1874340A4
EP1874340A4 EP06824685A EP06824685A EP1874340A4 EP 1874340 A4 EP1874340 A4 EP 1874340A4 EP 06824685 A EP06824685 A EP 06824685A EP 06824685 A EP06824685 A EP 06824685A EP 1874340 A4 EP1874340 A4 EP 1874340A4
Authority
EP
European Patent Office
Prior art keywords
methods
same
polyphenolics
elastin
protective polyphenolics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP06824685A
Other languages
German (de)
French (fr)
Other versions
EP1874340A2 (en
Inventor
Felipe Jimenez
Thomas Mitts
Aleksander Hinek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital for Sick Children HSC
Human Matrix Sciences LLC
Original Assignee
Hospital for Sick Children HSC
Human Matrix Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital for Sick Children HSC, Human Matrix Sciences LLC filed Critical Hospital for Sick Children HSC
Publication of EP1874340A2 publication Critical patent/EP1874340A2/en
Publication of EP1874340A4 publication Critical patent/EP1874340A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
EP06824685A 2005-03-29 2006-03-29 Elastin protective polyphenolics and methods of using the same Ceased EP1874340A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66596605P 2005-03-29 2005-03-29
US75882106P 2006-01-13 2006-01-13
PCT/US2006/012027 WO2007030145A2 (en) 2005-03-29 2006-03-29 Elastin protective polyphenolics and methods of using the same

Publications (2)

Publication Number Publication Date
EP1874340A2 EP1874340A2 (en) 2008-01-09
EP1874340A4 true EP1874340A4 (en) 2010-06-30

Family

ID=37836298

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06824685A Ceased EP1874340A4 (en) 2005-03-29 2006-03-29 Elastin protective polyphenolics and methods of using the same

Country Status (3)

Country Link
EP (1) EP1874340A4 (en)
CA (1) CA2603102C (en)
WO (1) WO2007030145A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114829B2 (en) 2005-02-22 2012-02-14 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
US8642578B2 (en) 2005-03-29 2014-02-04 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283349A1 (en) * 1987-02-20 1988-09-21 Jean-Louis Lamaison Process for obtaining tannic principles of vegetable origin, cosmetologic and pharmaceutical composition containing the tannic principle obtained by the process
FR2768927A1 (en) * 1997-10-01 1999-04-02 Lvmh Rech USE OF ELLAGIC ACID, ITS SALTS, ITS METAL COMPLEXES, ITS MONO- OR POLYMERIC, MONO- OR POLYACYLATED DERIVATIVES IN THE FIELD OF COSMETICS AND PHARMACY, IN PARTICULAR DERMATOLOGY
WO2000064472A1 (en) * 1999-04-22 2000-11-02 Howard Murad Methods and compositions for treating dermatological disorders with fruit extracts
US20020127256A1 (en) * 2001-03-01 2002-09-12 Howard Murad Compositions and methods for treating dermatological disorders
US20040120918A1 (en) * 2003-05-12 2004-06-24 Sederma S.A.S. Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides
US20040162232A1 (en) * 2003-02-14 2004-08-19 Thomas Mitts Elastin digest compositions and methods utilizing same
WO2005118783A1 (en) * 2004-05-28 2005-12-15 Human Matrix Sciences, Llc Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63313707A (en) * 1987-06-16 1988-12-21 Seven Kagaku:Kk Skin cosmetic
JP3393559B2 (en) * 1993-10-15 2003-04-07 株式会社ノエビア Skin preparation
JP2001072571A (en) * 1999-09-08 2001-03-21 Noevir Co Ltd Skin preparation for external use
EP1145709A1 (en) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Use of natural products to prepare cosmetic compositions
JP2002205913A (en) * 2001-01-10 2002-07-23 Ichimaru Pharcos Co Ltd Cosmetic composition
ES2274842T3 (en) * 2001-08-18 2007-06-01 Cognis Ip Management Gmbh MIXING OF ACTIVE PRINCIPLES.
JP2003128511A (en) * 2001-10-18 2003-05-08 Ichimaru Pharcos Co Ltd Agent for preventing aging of skin
US20040153145A1 (en) * 2002-11-26 2004-08-05 Clemson University Fixation method for bioprostheses
JP2006160685A (en) * 2004-12-09 2006-06-22 Jc Community:Kk Oral agent for preventing or ameliorating skin aging
US7566693B2 (en) * 2005-02-22 2009-07-28 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283349A1 (en) * 1987-02-20 1988-09-21 Jean-Louis Lamaison Process for obtaining tannic principles of vegetable origin, cosmetologic and pharmaceutical composition containing the tannic principle obtained by the process
FR2768927A1 (en) * 1997-10-01 1999-04-02 Lvmh Rech USE OF ELLAGIC ACID, ITS SALTS, ITS METAL COMPLEXES, ITS MONO- OR POLYMERIC, MONO- OR POLYACYLATED DERIVATIVES IN THE FIELD OF COSMETICS AND PHARMACY, IN PARTICULAR DERMATOLOGY
WO2000064472A1 (en) * 1999-04-22 2000-11-02 Howard Murad Methods and compositions for treating dermatological disorders with fruit extracts
US20020127256A1 (en) * 2001-03-01 2002-09-12 Howard Murad Compositions and methods for treating dermatological disorders
US20040162232A1 (en) * 2003-02-14 2004-08-19 Thomas Mitts Elastin digest compositions and methods utilizing same
US20040120918A1 (en) * 2003-05-12 2004-06-24 Sederma S.A.S. Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides
WO2005118783A1 (en) * 2004-05-28 2005-12-15 Human Matrix Sciences, Llc Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BUNDA S ET AL: "Fluctuations of intracellular iron modulate elastin production", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US LNKD- DOI:10.1074/JBC.M409897200, vol. 280, no. 3, 21 January 2005 (2005-01-21), pages 2341 - 2351, XP002346489, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
WO2007030145A2 (en) 2007-03-15
CA2603102A1 (en) 2007-03-15
EP1874340A2 (en) 2008-01-09
CA2603102C (en) 2015-08-11
WO2007030145A3 (en) 2009-04-16

Similar Documents

Publication Publication Date Title
IL228770A0 (en) Processes and intermaediates
IL185280A0 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
EP1846419A4 (en) Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
EP1895838A4 (en) Compositions and methods
EP1951680A4 (en) Novel 2-aminopyrimidinone derivatives and their use
IL189609A0 (en) 4-substituted pyrrolidin-2-ones and their use
IL191072A0 (en) Therapeutic compositions and methods
GB2430971B (en) Gas-tight and liquid-tight protective suit
EP1951682A4 (en) Novel 2-aminopyrimidinone or 2-aminopyridinone derivatives and their use
EP1861218A4 (en) Collet and lock nut
IL228531A0 (en) Mucin hypersecretion inhibitors based on the structure of mans and methods of use
IL189252A0 (en) Dihydroxyanthraquinones and their use
EP1912921A4 (en) Tetraazaporphyrin-based compounds and their uses
EP1921066A4 (en) Pyridylphenol compound and use thereof
EP1841730A4 (en) Cathepsin k inhibitors and atherosclerosis
IL185412A0 (en) Plant extracts and methods and uses therefore
EP1858509A4 (en) Novel cathepsin c inhibitors and their use
GB0501348D0 (en) Compositions and methods
EP1874340A4 (en) Elastin protective polyphenolics and methods of using the same
GB0520935D0 (en) Integrated processor-template-system and project
ZA200805245B (en) Combination of AXD2171 and pemetrexed
GB0502843D0 (en) Jig-was and jig-will
ZA200706741B (en) Tetrahydroindolone and tetrahydroindazolone derivatives
GB2431768B (en) Protective case
GB0522259D0 (en) e-s-spi-l-d-film-cinema-back-engineering armageddon-system and project

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071010

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

R17D Deferred search report published (corrected)

Effective date: 20090416

RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 19/08 20060101ALI20090417BHEP

Ipc: A61K 33/32 20060101ALI20090417BHEP

Ipc: A61P 17/16 20060101ALI20090417BHEP

Ipc: A61K 31/7024 20060101ALI20090417BHEP

Ipc: A61K 38/39 20060101ALI20090417BHEP

Ipc: A61K 31/366 20060101AFI20090417BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20100602

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/00 20060101ALI20100527BHEP

Ipc: A61K 8/64 20060101ALI20100527BHEP

Ipc: A61K 8/60 20060101ALI20100527BHEP

Ipc: A61K 8/49 20060101ALI20100527BHEP

Ipc: A61K 8/19 20060101ALI20100527BHEP

Ipc: A61K 33/34 20060101ALI20100527BHEP

Ipc: A61K 33/26 20060101ALI20100527BHEP

Ipc: A61K 31/39 20060101ALI20100527BHEP

Ipc: A61K 45/06 20060101ALI20100527BHEP

Ipc: A61Q 19/08 20060101ALI20100527BHEP

Ipc: A61K 33/32 20060101ALI20100527BHEP

Ipc: A61P 17/16 20060101ALI20100527BHEP

Ipc: A61K 31/7024 20060101ALI20100527BHEP

Ipc: A61K 38/39 20060101ALI20100527BHEP

Ipc: A61K 31/366 20060101AFI20090417BHEP

17Q First examination report despatched

Effective date: 20110921

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20140320